Literature DB >> 8174777

Postmitotic osteoclast precursors are mononuclear cells which express macrophage-associated phenotypes.

N Takahashi1, N Udagawa, S Tanaka, H Murakami, I Owan, T Tamura, T Suda.   

Abstract

We previously demonstrated that osteoclast-like multinucleated cells were formed within 6 days in cocultures of mouse osteoblastic cells and spleen cells in response to 1 alpha,25-dihydroxyvitamin D3[1 alpha,25(OH)2D3] which was added together with hydroxyurea on Days 4-6 (final 2 days of the 6-day coculture period). Using this coculture system, chronological changes of macrophage-associated phenotypes such as nonspecific esterase (NSE) and antigens to Mac-1, Mac-2, and F4/80 were examined in postmitotic osteoclast precursors during differentiation into osteoclasts induced by 1 alpha,25(OH)2D3 (10 nM) added on Day 4. Osteoclast differentiation was assessed by examining expression of calcitonin receptors (CTRs) by autoradiography using 125I-labeled salmon CT. CTRs were first detected on small mononuclear cells within 12 hr after adding 1 alpha,25(OH)2D3. The number of CTR-positive mononuclear cells attained a maximum at 24 hr and decreased thereafter. CTR-positive multinucleated cells were first observed at 24 hr and reached a maximum population at 48 hr. All CTR-positive cells showed tartrate-resistant acid phosphatase activity (a marker enzyme of osteoclasts). Most of the CTR-positive mononuclear cells which appeared at 12 hr were positive for NSE and antigens to Mac-1 and Mac-2, but negative for F4/80 antigen. The proportion of CTR-positive cells expressing NSE and Mac-1 to total CTR-positive mononuclear cells decreased time dependently. Like authentic osteoclasts, CTR-positive multinucleated cells were negative for NSE and antigens to Mac-1 and F4/80, but positive for Mac-2. These results indicate that postmitotic osteoclast precursors are mononuclear phagocytes with macrophage-associated phenotypes, some of which disappear rapidly during their differentiation into osteoclasts.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8174777     DOI: 10.1006/dbio.1994.1137

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  21 in total

1.  Thiocolchicoside suppresses osteoclastogenesis induced by RANKL and cancer cells through inhibition of inflammatory pathways: a new use for an old drug.

Authors:  Simone Reuter; Subash C Gupta; Kanokkarn Phromnoi; Bharat B Aggarwal
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  A novel osteoclast precursor cell line, 4B12, recapitulates the features of primary osteoclast differentiation and function: enhanced transfection efficiency before and after differentiation.

Authors:  Shigeru Amano; Keisuke Sekine; Lynda F Bonewald; Yoshihiro Ohmori
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

3.  Regulated proteolysis of nonmuscle myosin IIA stimulates osteoclast fusion.

Authors:  Brooke K McMichael; Robert B Wysolmerski; Beth S Lee
Journal:  J Biol Chem       Date:  2009-03-05       Impact factor: 5.157

4.  Human arthroplasty derived macrophages differentiate into osteoclastic bone resorbing cells.

Authors:  A Sabokbar; Y Fujikawa; S Neale; D W Murray; N A Athanasou
Journal:  Ann Rheum Dis       Date:  1997-07       Impact factor: 19.103

5.  Stepwise cell fate decision pathways during osteoclastogenesis at single-cell resolution.

Authors:  Masayuki Tsukasaki; Nam Cong-Nhat Huynh; Kazuo Okamoto; Ryunosuke Muro; Asuka Terashima; Yoshitaka Kurikawa; Noriko Komatsu; Warunee Pluemsakunthai; Takeshi Nitta; Takaya Abe; Hiroshi Kiyonari; Tadashi Okamura; Mashito Sakai; Toshiya Matsukawa; Michihiro Matsumoto; Yasuhiro Kobayashi; Josef M Penninger; Hiroshi Takayanagi
Journal:  Nat Metab       Date:  2020-12-07

6.  Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function.

Authors:  Firas M Kara; Violeta Chitu; Jennifer Sloane; Matthew Axelrod; Bertil B Fredholm; E Richard Stanley; Bruce N Cronstein
Journal:  FASEB J       Date:  2010-02-24       Impact factor: 5.191

7.  Negative regulation of osteoclast precursor differentiation by CD11b and β2 integrin-B-cell lymphoma 6 signaling.

Authors:  Kyung-Hyun Park-Min; Eun Young Lee; Neal K Moskowitz; Elisha Lim; Sun-Kyeong Lee; Joseph A Lorenzo; Chuanxin Huang; Ari M Melnick; P Edward Purdue; Steven R Goldring; Lionel B Ivashkiv
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

8.  Hyperglycemia induced and intrinsic alterations in type 2 diabetes-derived osteoclast function.

Authors:  D L Catalfamo; T M Britten; D L Storch; N L Calderon; H L Sorenson; S M Wallet
Journal:  Oral Dis       Date:  2013-04       Impact factor: 3.511

9.  Augmented LPS responsiveness in type 1 diabetes-derived osteoclasts.

Authors:  Dana L Catalfamo; Nadia L Calderon; Scott W Harden; Heather L Sorenson; Kathleen G Neiva; Shannon M Wallet
Journal:  J Cell Physiol       Date:  2013-02       Impact factor: 6.384

Review 10.  Osteoclasts-Key Players in Skeletal Health and Disease.

Authors:  Deborah Veis Novack; Gabriel Mbalaviele
Journal:  Microbiol Spectr       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.